Regenfast gel for jaw bone damage from osteoporosis drugs
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This trial tests a gel made from polynucleotides and hyaluronic acid (Regenfast) to help heal jaw bone damage caused by osteoporosis or cancer medications (MRONJ). It is for people with early-stage MRONJ who need surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with stage 1 or stage 2 MRONJ
- You are planning to have surgery for this condition
- You have not had radiation therapy to the head or neck
- You are not pregnant
- You can attend follow-up visits at the clinic
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether putting a special blood concentrate from your own platelets into the tooth socket after an extraction helps the bone heal better and prevent a serious jaw condition (MRONJ) in people at high risk due to certain medications like bisphosphonates or denosumab.
This study compares two ways to treat a jaw bone problem caused by medications (called MRONJ) when it happens around a dental implant. One option is to keep the implant and treat the bone, the other is to remove the implant. The goal is to see which approach leads to better healing.
This trial tests whether using a special blood product (leukocyte- and platelet-rich fibrin, or L-PRF) during surgery for a jawbone condition called MRONJ helps improve healing. Patients who need surgery under general anesthesia for advanced MRONJ may be able to join.
This Phase 2 trial studies whether a human amniotic membrane dressing can help heal stage II maxillomandibular osteonecrosis of the jaw (MRONJ). It focuses on people who developed MRONJ after certain cancer-related bone treatments and who may need surgery and antibiotics.
This trial tests a surgical technique using a double tissue flap to close the jawbone in patients with medication-related osteonecrosis of the jaw (MRONJ). The goal is to improve healing and reduce complications.
This trial tests a combination of medicines (pentoxifylline and tocopherol, a form of vitamin E) to treat damage to the jaw bone caused by bone-strengthening drugs. If you have Stage 2 MRONJ and meet other criteria, this treatment may help heal the bone.
Hear when a new Medication Related Osteonecrosis of the Jaw trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.